Differentiating Chondrocytes from Peripheral Blood-derived Human Induced Pluripotent Stem Cells

Area of Science:

• Regenerative Medicine
• Stem Cell Biology
• Tissue Engineering

Background:

• Cartilage repair remains a significant clinical challenge.
• Induced pluripotent stem cells (iPSCs) offer potential for regenerative therapies.
• Developing efficient and patient-specific cell sources is crucial.

Purpose of the Study:

• To investigate the potential of peripheral blood cells (PBCs) as a source for generating chondrocytes via induced pluripotent stem cells (iPSCs).
• To establish an integration-free method for chondrogenic differentiation of iPSCs derived from PBCs.
• To evaluate the efficacy and characteristics of the generated chondrocytes for cartilage repair applications.

Main Methods:

• Peripheral blood cells (PBCs) were reprogrammed into integration-free induced pluripotent stem cells (iPSCs).
• Embryoid bodies (EBs) were formed, followed by fibroblastic cell expansion.
• Chondrogenic differentiation was induced for 21 days under serum-free and xeno-free conditions.
• Cell phenotypes were assessed using morphological, immunohistochemical, biochemical, and quantitative real-time PCR analyses.

Main Results:

• Chondrogenic pellets exhibited positive staining for Alcian blue and Toluidine blue.
• Immunohistochemistry confirmed positive staining for Collagen II and Collagen X.
• Significant upregulation of sulfated glycosaminoglycan (sGAG) content and chondrogenic markers (COL2, COL10, SOX9, AGGRECAN) was observed.
• Generated chondrocytes demonstrated characteristic phenotypes compared to hiPSCs and fibroblastic cells.

Conclusions:

• Peripheral blood cells (PBCs) are a viable source for generating patient-specific induced pluripotent stem cells (iPSCs).
• This method successfully produced chondrocytes with validated differentiation markers.
• The developed approach offers a cost-effective and potentially valuable strategy for cartilage repair therapies.